TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 348536

Group type: COMPARATOR
Intervention: Metopimazine 30 mg/day or 15 mg/day
Number of subjects: 183

Group type: COMPARATOR
Intervention: Metopimazine 45 mg/day
Number of subjects: 183
Study: 31123552

Group type: EXPERIMENTAL
Intervention: Fab antivenom (FabAV)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study: 28211112

Group type: EXPERIMENTAL
Intervention: Direct marketing price promotion (Buywell) combined with healthy eating advice and recipe suggestions
Number of subjects: 53367

Group type: EXPERIMENTAL
Intervention: Direct marketing price promotion (Buywell)
Number of subjects: 53367
Study: 25659142

Group type: EXPERIMENTAL
Intervention: Homeless‐tailored service design
Number of subjects: 366

Group type: COMPARATOR
Intervention: Mainstream primary care clinics (VA)
Number of subjects: 366

Group type: COMPARATOR
Intervention: Tailored non‐VA healthcare program
Number of subjects: 366
Study: 24072965

Group type: EXPERIMENTAL
Intervention: Telephone-delivered psychoeducational intervention (12 sessions)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (DVD containing educational information about dementia caregiving)
Number of subjects: 38
Study: 21332450

Group type: EXPERIMENTAL
Intervention: Immediate catheter removal
Number of subjects: 70

Group type: COMPARATOR
Intervention: Delayed catheter removal
Number of subjects: 70
Study: 19236356

Group type: EXPERIMENTAL
Intervention: Buprenorphine treatment for heroin dependence
Number of subjects: 62
Study: 16445448

Group type: EXPERIMENTAL
Intervention: Limbal anaesthesia
Number of subjects: 117

Group type: COMPARATOR
Intervention: Topical anaesthesia
Number of subjects: 117
Study: 15301642

Group type: EXPERIMENTAL
Intervention: Narrative Exposure Therapy (NET)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Supportive Counseling (SC)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Psychoeducation (PE)
Number of subjects: 43
Study: 10742705

Group type: EXPERIMENTAL
Intervention: Exercise programme (once weekly sessions for 12 weeks)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control component
Number of subjects: 22
Study: 9076618

Group type: EXPERIMENTAL
Intervention: Rice-based oral rehydration solution (ORS)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Glucose oral rehydration solution (ORS)
Number of subjects: 100
Study: 8376450

Group type: EXPERIMENTAL
Intervention: Chevron metatarsal osteotomy
Number of subjects: 51

Group type: COMPARATOR
Intervention: Wilson metatarsal osteotomy
Number of subjects: 51
Study: 3024869

Group type: EXPERIMENTAL
Intervention: Atropine (cholinergic blockade)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control (no atropine)
Number of subjects: 6
Study: 30858203

Group type: EXPERIMENTAL
Intervention: Daptomycin plus Ceftaroline (DAPCPT) - 6 to 8 mg/kg of body weight per day of DAP and 600 mg intravenous CPT every 8 hours (n 17)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard monotherapy - Vancomycin (VAN; dosed to achieve serum trough concentrations of 15 to 20 mg/liter; n 21) or 6 to 8 mg/kg/day DAP (n 2) (n 23 total)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Daptomycin plus Ceftaroline (DAPCPT) - among patients with IL-10 concentration of 5 pg/ml (n 14)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard monotherapy - among patients with IL-10 concentration of 5 pg/ml (n 19)
Number of subjects: 40
Study: 29993140

Group type: EXPERIMENTAL
Intervention: Standardised oral health examination by registered dental hygienists
Number of subjects: 559
Study: 26625401

Group type: EXPERIMENTAL
Intervention: NeuCube SNN model
Number of subjects: 3

Group type: COMPARATOR
Intervention: Traditional statistical and artificial intelligence methods
Number of subjects: 3
Study: 24648103

Group type: EXPERIMENTAL
Intervention: 3-item clinical prediction rule for recovery from acute LBP
Number of subjects: 956
Study: 22686185

Group type: EXPERIMENTAL
Intervention: 18 months of weekly psychoanalytic psychotherapy, manualised and fidelity‐assessed using the Psychotherapy Process Q‐Sort.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual, managed by the referring practitioner.
Number of subjects: 0
Study: 20830664

Group type: EXPERIMENTAL
Intervention: Desvenlafaxine (50, 100, 200, or 400 mg/d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18555464

Group type: EXPERIMENTAL
Intervention: High dose chemotherapy (HDCT) with melphalan 200 mg/m² and autologous peripheral stem cell transplantation (APSCT)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Thalidomide maintenance therapy at 100 mg/day
Number of subjects: 37
Study: 15751598

Group type: EXPERIMENTAL
Intervention: Participatory community-media intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Key informant community readiness assessments
Number of subjects: 0
Study: 11843743

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 180

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 180
Study: 10382465

Group type: EXPERIMENTAL
Intervention: Early discharge follow-up program
Number of subjects: 639

Group type: COMPARATOR
Intervention: Standard care (before the program)
Number of subjects: 639
Study: 7586952

Group type: EXPERIMENTAL
Intervention: Norepinephrine (1, 2, and 4 micrograms/kg)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Phentolamine (10 mg, intravenous)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Prazosin (5 mg, orally)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Nicardipine (2 micrograms/kg/min, continuous intravenous infusion)
Number of subjects: 7
Study: 2254715

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Multiple injections (MI) with human isophane insulin
Number of subjects: 52

Group type: COMPARATOR
Intervention: Conventional therapy (CT)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Multiple injections (MI) with human ultralente insulin
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Intensified therapy (CSII and MI)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Intensified insulin therapy (CSII and MI)
Number of subjects: 52
Study: 7029388

Group type: EXPERIMENTAL
Intervention: Topical 1% aqueous indomethacin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no indomethacin)
Number of subjects: 0
Study: 31646414

Group type: EXPERIMENTAL
Intervention: High-dose spinal analgesia (levobupivacaine 7.5 mg plus sufentanil 2.5 μg)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Low-dose spinal analgesia (levobupivacaine 3.75 mg plus sufentanil 2.5 μg)
Number of subjects: 102

Group type: COMPARATOR
Intervention: General anaesthesia alone
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: High-dose spinal analgesia during laparoscopy
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Low-dose spinal analgesia during laparoscopy
Number of subjects: 102

Group type: COMPARATOR
Intervention: General anaesthesia during laparoscopy
Number of subjects: 102
Study: 31318233

Group type: EXPERIMENTAL
Intervention: go/no-go training with smoking stimuli
Number of subjects: 107

Group type: COMPARATOR
Intervention: go/no-go training with nonsmoking stimuli (control)
Number of subjects: 107
Study: 28295463

Group type: EXPERIMENTAL
Intervention: RG-101 2 mg/kg (n = 14)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: RG-101 4 mg/kg (n = 14)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: RG-101 (both dosages combined)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (n = 2)
Number of subjects: 32
Study: 26354535

Group type: EXPERIMENTAL
Intervention: Weight variability measured over the initial 6 months using root mean square error approach.
Number of subjects: 171

Group type: COMPARATOR
Intervention: Control for baseline body mass index (BMI) and BMI change from baseline to 6 months, as well as measures of disinhibition, restrained eating, and dieting.
Number of subjects: 171
Study: 23685845

Group type: EXPERIMENTAL
Intervention: Sildenafil treatment
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Sildenafil treatment in ED/DM group
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 44
Study: 21271365

Group type: EXPERIMENTAL
Intervention: Tailored intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Public web site
Number of subjects: 0

Group type: COMPARATOR
Intervention: Survey-only group
Number of subjects: 0
Study: 19898073

Group type: EXPERIMENTAL
Intervention: Unstable sandals for 6 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Regular golf shoes for 6 weeks (Control)
Number of subjects: 40
Study: 17943620

Group type: EXPERIMENTAL
Intervention: Motivational telephone counseling intervention (MI)
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: Three MI calls
Number of subjects: 358

Group type: COMPARATOR
Intervention: No telephone calls
Number of subjects: 358
Study: 15569128

Group type: EXPERIMENTAL
Intervention: Structured reinforcement of diabetic health education by a trained nurse every 3 months
Number of subjects: 180

Group type: COMPARATOR
Intervention: Standard medical care without nursing reinforcement
Number of subjects: 180
Study: 11139544

Group type: EXPERIMENTAL
Intervention: Misoprostol (400 microgram, vaginally)
Number of subjects: 274

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Misoprostol (in clomiphene cycles)
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Misoprostol (in FSH cycles)
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Misoprostol (in natural cycles)
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Misoprostol (in clomiphene/FSH cycles)
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 274
Study: 9022526

Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (clamping when the cord stopped pulsating, infant at the level of the placenta)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (clamping when the cord stopped pulsating, newborn below the level of the placenta)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Immediate cord clamping (control group)
Number of subjects: 69
Study: 8154425

Group type: EXPERIMENTAL
Intervention: Nicorandil
Number of subjects: 25

Group type: COMPARATOR
Intervention: Nitroglycerin (GTN)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 25
Study: 3127431

Group type: EXPERIMENTAL
Intervention: Rioprostil 60, 120, and 300 micrograms four times per day
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 31666995

Group type: EXPERIMENTAL
Intervention: Warm-up with post-activation potentiation (PAP) sets (2 × 5 repetitions of unloaded countermovement jump)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Warm-up with post-activation potentiation (PAP) sets
Number of subjects: 16

Group type: COMPARATOR
Intervention: Standard warm-up (non-PAP; control condition)
Number of subjects: 16
Study: 30153859

Group type: EXPERIMENTAL
Intervention: suPAR measurement at arrival in emergency department
Number of subjects: 16801

Group type: COMPARATOR
Intervention: No suPAR measurement in emergency department
Number of subjects: 16801

Group type: EXPERIMENTAL
Intervention: suPAR measurement
Number of subjects: 16801
Study: 26337285

Group type: EXPERIMENTAL
Intervention: Insulin initiation checklist
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (no checklist)
Number of subjects: 64
Study: 25220898

Group type: EXPERIMENTAL
Intervention: Pain that at least moderately interfered with daily living
Number of subjects: 699
Study: 23194489

Group type: EXPERIMENTAL
Intervention: Atrial fibrillation/flutter (AF/AFL)
Number of subjects: 4133

Group type: COMPARATOR
Intervention: Sinus rhythm (SR)
Number of subjects: 4133
Study: 20162301

Group type: EXPERIMENTAL
Intervention: Cold Water Immersion (CWI) 14 degrees C
Number of subjects: 10
Study: 18607311

Group type: EXPERIMENTAL
Intervention: SAFE intervention
Number of subjects: 477

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 477
Study: 15869558

Group type: EXPERIMENTAL
Intervention: Home physiotherapy (pre- and post-operative home visits by a community physiotherapist)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Hospital outpatient physiotherapy
Number of subjects: 160
Study: 15022656

Group type: EXPERIMENTAL
Intervention: True acupuncture interventions
Number of subjects: 47

Group type: COMPARATOR
Intervention: Sham acupuncture interventions
Number of subjects: 47
Study: 10327378

Group type: EXPERIMENTAL
Intervention: Clomipramine 25 mg
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 7562355

Group type: EXPERIMENTAL
Intervention: Bioresorbable matrix barrier (test)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Nonresorbable expanded polytetrafluoroethylene (ePTFE) barrier (control)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control treatment (nonresorbable barrier)
Number of subjects: 38
Study: 2075848

Group type: EXPERIMENTAL
Intervention: Televised self-help cigarette smoking cessation intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Attending three weekly support meetings during the program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not attending support meetings
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Meeting sample
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other sample (not attending meetings)
Number of subjects: 0
Study: 7033946

Group type: EXPERIMENTAL
Intervention: 200 mg metoprolol
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 2.5 mg indapamide
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Combination of 200 mg metoprolol and 2.5 mg indapamide
Number of subjects: 27
Study: 31980886

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine infusion (1.5 mg/kg bolus followed by 1.5 mg/kg/h continuous infusion)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 48
Study: 31796179

Group type: EXPERIMENTAL
Intervention: Afoxolaner (2.7-6.9 mg/kg, PO)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Ivermectin (300 μg/kg, SC)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Untreated
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Afoxolaner (monthly treatment for heavy infestations)
Number of subjects: 16
Study: 29090299

Group type: EXPERIMENTAL
Intervention: Palm oil (PO, 22.25 g)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Rice bran oil (RBO, 22.25 g)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Palm oleogel (PG, 22.25 g oil + 2.75 g EC)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Rice bran oleogel (RBG, 22.25 g oil + 2.75 g EC)
Number of subjects: 18

Group type: COMPARATOR
Intervention: No oil control
Number of subjects: 18
Study: 26534948

Group type: EXPERIMENTAL
Intervention: Pre-dive checklist and post-dive log
Number of subjects: 1043

Group type: COMPARATOR
Intervention: Post-dive log only
Number of subjects: 1043
Study: 24906838

Group type: COMPARATOR
Intervention: Nutrition counseling during radiotherapy, with at least three sessions of individualized dietary counseling.
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Nutrition counseling during radiotherapy.
Number of subjects: 87
Study: 22196424

Group type: EXPERIMENTAL
Intervention: High-velocity low-amplitude (HVLA) manipulation to the SIJ
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both SIJ and lumbar HVLA manipulation
Number of subjects: 32
Study: 19394503

Group type: EXPERIMENTAL
Intervention: Nicardipine (0.5 microg/kg/min continuous infusion)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 100
Study: 17533211

Group type: EXPERIMENTAL
Intervention: Statin Choice decision aid
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control pamphlet about cholesterol management
Number of subjects: 98
Study: 15232500

Group type: EXPERIMENTAL
Intervention: 5,000 U of Botulinum toxin type B (BTX-B) treatment
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 12368670

Group type: EXPERIMENTAL
Intervention: Pancreatic duct occlusion without anastomosis
Number of subjects: 169

Group type: COMPARATOR
Intervention: Pancreaticojejunostomy
Number of subjects: 169
Study: 9839762

Group type: EXPERIMENTAL
Intervention: Donepezil HCl (5 mg)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Cimetidine (800 mg)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Donepezil + Cimetidine (5 mg + 800 mg)
Number of subjects: 19
Study: 7868435

Group type: EXPERIMENTAL
Intervention: Cycle ergometer conditioning (heart rate of 145 beats/min at 25 min/day for 3 days/wk)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Cycle ergometer conditioning
Number of subjects: 38

Group type: COMPARATOR
Intervention: Nonexercising pregnant control women
Number of subjects: 38
Study: 2631519

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX) 1200 mg/day
Number of subjects: 208

Group type: COMPARATOR
Intervention: Combination of acetylsalicylic acid (ASA, 1050 mg/day) and dipyridamole (D, 150 mg/day)
Number of subjects: 208
Study: 1023953

Group type: EXPERIMENTAL
Intervention: Aluminium hydroxide 40 ml
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Sodium citrate 30 ml
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Magnesium trisilicate 30 ml
Number of subjects: 200

Group type: COMPARATOR
Intervention: Diazepam 10 mg alone
Number of subjects: 200
Study: 31521645

Group type: EXPERIMENTAL
Intervention: DK crush stenting
Number of subjects: 482

Group type: COMPARATOR
Intervention: Provisional stenting (PS)
Number of subjects: 482
Study: 27940183

Group type: EXPERIMENTAL
Intervention: Education plus navigation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Education only
Number of subjects: 0
Study: 25863464

Group type: EXPERIMENTAL
Intervention: Progressive task-oriented training on the tilt table
Number of subjects: 39

Group type: COMPARATOR
Intervention: Tilt table group
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 39
Study: 22999847

Group type: EXPERIMENTAL
Intervention: Corticosteroid injection (subacromial, intra-articular, intra-articular combined with subacromial)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Medication (control group IV)
Number of subjects: 191
Study: 21332807

Group type: EXPERIMENTAL
Intervention: Syndet bar
Number of subjects: 0

Group type: COMPARATOR
Intervention: One soap bar
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both soap bars
Number of subjects: 0
Study: 19769472

Group type: EXPERIMENTAL
Intervention: Ultraviolet (UV) light exposure
Number of subjects: 19

Group type: COMPARATOR
Intervention: Non-UV (control) exposure
Number of subjects: 19
Study: 17163358

Group type: EXPERIMENTAL
Intervention: Calcitriol 1.5 mcg/die plus hydrochlorothiazide
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo (mineral integrates)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Calcitriol plus hydrochlorothiazide
Number of subjects: 42
Study: 15120537

Group type: EXPERIMENTAL
Intervention: Nonfluent aphasia group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluent aphasia group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control participants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonfluent aphasic participants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluent aphasic participants
Number of subjects: 0
Study: 10775552

Group type: EXPERIMENTAL
Intervention: High-salt diet (255 mmol/d)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Low-salt diet (50 mmol/d)
Number of subjects: 20
Study: 9322806

Group type: EXPERIMENTAL
Intervention: tolrestat (200 mg daily)
Number of subjects: 18

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 18
Study: 1587168

Group type: EXPERIMENTAL
Intervention: First-degree relatives (FDR)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: FDRs with two or more afflicted FDRs
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: FDRs with one afflicted FDR
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: FDRs
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Male FDRs over the age of 50
Number of subjects: 181

Group type: COMPARATOR
Intervention: Age-matched male controls
Number of subjects: 181
Study: 3919803

Group type: EXPERIMENTAL
Intervention: Cimetidine 1 g daily for one month
Number of subjects: 16

Group type: COMPARATOR
Intervention: Ranitidine 300 mg daily for one month
Number of subjects: 16
Study: 30195986

Group type: EXPERIMENTAL
Intervention: Couples Caring and Relating with Empathy intervention (16-week, 2-hour sessions)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Waitlist-controlled group
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Couples Caring and Relating with Empathy intervention
Number of subjects: 44
Study: 29030237

Group type: EXPERIMENTAL
Intervention: CFS-guided ablation
Number of subjects: 128

Group type: COMPARATOR
Intervention: CFS-blinded ablation
Number of subjects: 128
Study: 27030891

Group type: EXPERIMENTAL
Intervention: Hestia criteria combined with NT-proBNP testing
Number of subjects: 550

Group type: COMPARATOR
Intervention: Direct discharge (Hestia criteria alone)
Number of subjects: 550
Study: 22592579

Group type: EXPERIMENTAL
Intervention: Educational intervention in LLINs area
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control area with untreated nets
Number of subjects: 0
Study: 20925642

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (400 mg twice daily)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (400 mg twice daily) + Topical honey ointment
Number of subjects: 150

Group type: COMPARATOR
Intervention: Standard burn treatment (Control group)
Number of subjects: 150
Study: 18569935

Group type: EXPERIMENTAL
Intervention: Lactated Ringer's (LR)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Normal Saline (NS)
Number of subjects: 2
Study: 15377823

Group type: EXPERIMENTAL
Intervention: Levonorgestrel-releasing intrauterine device (LNG-IUD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Thermal balloon ablation (TBA)
Number of subjects: 0
Study: 12419025

Group type: EXPERIMENTAL
Intervention: Teledermatology consultation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care consultation
Number of subjects: 0
Study: 11090092

Group type: EXPERIMENTAL
Intervention: Thalidomide (200 mg orally per day, increased to 800 mg/d if tolerable)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 9200358

Group type: EXPERIMENTAL
Intervention: Infasurf
Number of subjects: 871